HUP0300602A3 - Diazabicyclic central nervous system active agents, pharmaceutical compositions containing them and their use - Google Patents

Diazabicyclic central nervous system active agents, pharmaceutical compositions containing them and their use

Info

Publication number: HUP0300602A3
Authority: HU; Hungary
Prior art keywords: pharmaceutical compositions; nervous system; active agents; compositions containing; central nervous
Prior art date: 2000-04-27

Application number

HU0300602A

Other languages

English (en)

Original Assignee

Abbott Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-04-27

Filing date

2001-04-27

Publication date

2005-12-28

2001-04-12 Priority claimed from US09/833,914 external-priority patent/US6809105B2/en

2001-04-27 Application filed by Abbott Lab filed Critical Abbott Lab

2003-06-28 Publication of HUP0300602A2 publication Critical patent/HUP0300602A2/hu

2005-12-28 Publication of HUP0300602A3 publication Critical patent/HUP0300602A3/hu

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Psychology (AREA)
Addiction (AREA)
Anesthesiology (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Gynecology & Obstetrics (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

HU0300602A 2000-04-27 2001-04-27 Diazabicyclic central nervous system active agents, pharmaceutical compositions containing them and their use HUP0300602A3 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US55994300A	2000-04-27	2000-04-27
US09/833,914 US6809105B2 (en)	2000-04-27	2001-04-12	Diazabicyclic central nervous system active agents
PCT/US2001/013798 WO2001081347A2 (en)	2000-04-27	2001-04-27	Diazabicyclic central nervous system active agents

Publications (2)

Publication Number	Publication Date
HUP0300602A2 HUP0300602A2 (hu)	2003-06-28
HUP0300602A3 true HUP0300602A3 (en)	2005-12-28

Family

ID=27072208

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HU0300602A HUP0300602A3 (en)	2000-04-27	2001-04-27	Diazabicyclic central nervous system active agents, pharmaceutical compositions containing them and their use

Country Status (22)

Country	Link
EP (3)	EP2298775A1 (hu)
JP (2)	JP4981232B2 (hu)
KR (4)	KR100961406B1 (hu)
CN (3)	CN102863441A (hu)
AR (1)	AR030421A1 (hu)
AU (2)	AU2001266559C1 (hu)
BG (2)	BG66151B1 (hu)
BR (1)	BR0107246A (hu)
CA (2)	CA2683045A1 (hu)
CZ (4)	CZ302795B6 (hu)
HK (1)	HK1054375A1 (hu)
HU (1)	HUP0300602A3 (hu)
IL (3)	IL152231A0 (hu)
MX (1)	MXPA02010594A (hu)
MY (3)	MY137020A (hu)
NO (1)	NO324250B1 (hu)
NZ (1)	NZ521734A (hu)
PE (1)	PE20011305A1 (hu)
PL (2)	PL398491A1 (hu)
SK (2)	SK287658B6 (hu)
TW (4)	TWI311137B (hu)
WO (1)	WO2001081347A2 (hu)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE380031T1 (de)	1999-12-10	2007-12-15	Pfizer Prod Inc	Pyrrolo 2,3-d pyrimidinderivate enthaltende zusammensetzungen
SE0100326D0 (sv) *	2001-02-02	2001-02-02	Astrazeneca Ab	New compounds
PL377791A1 (pl) *	2002-11-21	2006-02-20	Pfizer Products Inc.	Pochodne 3-aminopiperydyny i sposoby ich wytwarzania
US7354937B2 (en)	2004-05-21	2008-04-08	Abbott Laboratories	(1S,5S)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane
US20040242641A1 (en) *	2003-05-27	2004-12-02	Buckley Michael J.	(1S,5S)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane is an effective analgesic agent
US20050261348A1 (en) *	2004-05-21	2005-11-24	Buckley Michael J	(1S,5S)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane is an effective analgesic agent
US20050043407A1 (en) *	2003-08-22	2005-02-24	Pfizer Inc	Pharmaceutical composition for the prevention and treatment of addiction in a mammal
US7399765B2 (en)	2003-09-19	2008-07-15	Abbott Laboratories	Substituted diazabicycloalkane derivatives
US20050065178A1 (en) *	2003-09-19	2005-03-24	Anwer Basha	Substituted diazabicycloakane derivatives
GB0322140D0 (en) *	2003-09-22	2003-10-22	Pfizer Ltd	Combinations
US8580842B2 (en)	2003-09-30	2013-11-12	Abbott Gmbh & Co. Kg	Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them
US20050171079A1 (en)	2004-02-04	2005-08-04	Schrimpf Michael R.	Amino-substituted tricyclic derivatives and methods of use
CA2565211A1 (en)	2004-04-29	2005-11-24	Abbott Laboratories	Amino-tetrazoles analogues and methods of use
US7351833B2 (en)	2004-07-23	2008-04-01	Abbott Laboratories	(1S,5S)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane benzenesulfonate
ES2391472T3 (es) *	2005-12-20	2012-11-27	Astrazeneca Ab	Derivados de cinnolina sustituidos como moduladores del receptor de GABAA y método para su síntesis
US20070184490A1 (en) *	2006-01-17	2007-08-09	Marleen Verlinden	Neuronal nicotinic receptor ligands and their use
US7728031B2 (en)	2006-02-24	2010-06-01	Abbott Laboratories	Octahydro-pyrrolo[3,4-b]pyrrole derivatives
US20100234349A1 (en)	2006-09-04	2010-09-16	Olsen Gunnar M	Pharmaceutical combinations of a nicotine receptor modulator and a cognitive enhancer
US20080167286A1 (en)	2006-12-12	2008-07-10	Abbott Laboratories	Pharmaceutical compositions and their methods of use
US8486979B2 (en)	2006-12-12	2013-07-16	Abbvie Inc.	1,2,4 oxadiazole compounds and methods of use thereof
US8076350B2 (en)	2006-12-22	2011-12-13	Abbott Laboratories	Spirocyclic azaadamantane derivatives and methods of use
UY30846A1 (es)	2006-12-30	2008-07-31	Abbott Gmbh & Amp	Derivados de oxindol sustituidos, medicamentos que los comprenden y uso de los mismos
US8163916B2 (en)	2007-03-23	2012-04-24	Abbott Laboratories	Azaadamantane ester and carbamate derivatives and methods of use thereof
WO2009036132A1 (en)	2007-09-11	2009-03-19	Abbott Laboratories	Octahydro-pyrrolo[3,4-b]pyrrole n-oxides
PA8802501A1 (es)	2007-10-31	2009-06-23	Janssen Pharmaceutica Nv	Diaminas en puente o fusionadas sustituidas con arilo como moduladores de leucotrieno, hidrolasa
EP2231672B1 (en) *	2007-11-21	2014-12-17	AbbVie Inc.	BIARYL SUBSTITUTED DIAZABICYCLOHEPTANE DERIVATIVES AS nAChR MODULATORS
MX2010006202A (es)	2007-12-07	2011-03-04	Abbott Gmbh & Co Kg	Derivados de oxindol substituidos por amidometil y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina.
WO2009071690A2 (de)	2007-12-07	2009-06-11	Abbott Gmbh & Co. Kg	5,6-disubstituierte oxindol-derivate und ihre verwendung zur behandlung von vasopressin-abhängigen erkrankungen
WO2010009775A1 (de)	2007-12-07	2010-01-28	Abbott Gmbh & Co. Kg	Carbamat-substituierte oxindol-derivate und ihre verwendung zur behandlung von vasopressin-abhängigen erkrankungen
CA2707669C (en)	2007-12-07	2016-07-05	Wilfried Braje	5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases
ES2380398T3 (es)	2007-12-18	2012-05-11	Actelion Pharmaceuticals Ltd.	Derivados 5-aminociclilmetil-oxazolidin-2-ona
BRPI0911336A2 (pt)	2008-04-11	2021-06-29	Janssen Pharmaceutica N.V.	tiazolopiridin-2-iloxifenil e tiazolopirazin-2-iloxifenil aminas como moduladores de leucotrieno a4 hidrolase
US8148408B2 (en)	2008-05-09	2012-04-03	Abbott Laboratories	Selective substituted pyridine ligands for neuronal nicotinic receptors
EP2411012A4 (en) *	2009-03-24	2012-08-22	Msd Kk	NEW AMINO-PYRIDINE DERIVATIVES WITH SELECTIVE AURORA A INHIBITION
NZ596137A (en)	2009-05-14	2013-08-30	Janssen Pharmaceutica Nv	Compounds with two fused bicyclic heteroaryl moieties as modulators of leukotriene a4 hydrolase
WO2010138600A2 (en)	2009-05-29	2010-12-02	Abbott Laboratories	Pharmaceutical compositions for the treatment of pain
WO2010151815A2 (en)	2009-06-25	2010-12-29	Abbott Laboratories	3,9-diazaspiro[5,5]undecane amides and ureas and methods of use thereof
PL2473049T3 (pl)	2009-09-04	2019-07-31	Biogen Ma Inc.	Inhibitory kinazy tyrozynowej brutona
RS54945B1 (sr)	2009-10-23	2016-11-30	Janssen Pharmaceutica Nv	Disupstituisani oktahidropirolo[3,4-c]piroli kao oreksin receptor modulatori
US9062044B2 (en) *	2009-10-23	2015-06-23	Janssen Pharmaceutica Nv	Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators
WO2011050200A1 (en)	2009-10-23	2011-04-28	Janssen Pharmaceutica Nv	Fused heterocyclic compounds as orexin receptor modulators
WO2012145581A1 (en)	2011-04-20	2012-10-26	Janssen Pharmaceutica Nv	Disubstituted octahy-dropyrrolo [3,4-c] pyrroles as orexin receptor modulators
AR091273A1 (es)	2012-06-08	2015-01-21	Biogen Idec Inc	Inhibidores de pirimidinil tirosina quinasa
KR101655787B1 (ko)	2014-05-08	2016-09-22	대우조선해양 주식회사	선박의 하이브리드 공기조화시스템 및 그 방법, 그리고 이를 포함하는 선박 또는 해양구조물
KR20160021679A (ko)	2014-08-18	2016-02-26	대우조선해양 주식회사	극저온 환경의 장비용 히팅장치 및 방법 그리고 이를 구비하는 선박
KR20170090422A (ko)	2014-10-31	2017-08-07	인디비어 유케이 리미티드	도파민 d3 수용체 길항제 화합물
DK3426251T3 (da)	2016-03-10	2022-06-20	Janssen Pharmaceutica Nv	Fremgangsmåder til behandling af depression under anvendelse af orexin-2-receptorantagonister
WO2018017153A1 (en)	2016-07-21	2018-01-25	Biogen Ma Inc.	Succinate forms and compositions of bruton's tyrosine kinase inhibitors
CN109843872B (zh) *	2017-09-20	2022-08-30	杭州英创医药科技有限公司	作为ido抑制剂和/或ido-hdac双重抑制剂的多环化合物
GB201809295D0 (en)	2018-06-06	2018-07-25	Institute Of Cancer Res Royal Cancer Hospital	Lox inhibitors
CR20210240A (es)	2018-11-14	2021-06-08	Janssen Pharmaceutica Nv	Métodos sintéticos mejorados para elaborar compuestos heterocíclicos fusionados como moduladores del receptor de orexina
EP3978497A4 (en) *	2019-05-30	2022-07-13	Shanghai Institute of Materia Medica, Chinese Academy of Sciences	FUSED CYCLIC COMPOUND, METHOD FOR PREPARING IT AND ITS USE
CN112047878B (zh) *	2020-10-15	2022-04-19	郑州猫眼农业科技有限公司	4-溴-6-氯吡啶-2-羧酸的制备方法
WO2024189472A1 (en)	2023-03-14	2024-09-19	Janssen Pharmaceutica Nv	Improved synthetic methods of making substituted pyrimidine intermediates for synthesis of orexin receptor modulators

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK0393424T3 (da)	1989-04-17	1996-02-05	Bayer Ag	Fremgangsmåde til fremstilling af 2,7-diazabicyclo(3.3.0)octaner
NL9201810A (nl)	1992-10-19	1994-05-16	Dsm Nv	Werkwijze voor de omzetting van een olefine of een olefinemengsel.
CA2112165C (en)	1992-12-25	2003-04-08	Makoto Takemura	Bicyclic amine derivatives
US5817679A (en) *	1993-04-01	1998-10-06	University Of Virginia	7-Azabicyclo 2.2.1!-heptane and -heptene derivatives as cholinergic receptor ligands
US5478939A (en) *	1994-07-20	1995-12-26	American Cyanamid Company	(R,R) and (S,S) 2,5-diazabicyclo [2,2,1]heptane derivatives
US5472958A (en)	1994-08-29	1995-12-05	Abbott Laboratories	2-((nitro)phenoxymethyl) heterocyclic compounds that enhance cognitive function
US5585388A (en)	1995-04-07	1996-12-17	Sibia Neurosciences, Inc.	Substituted pyridines useful as modulators of acetylcholine receptors
JP4176147B2 (ja) *	1995-07-28	2008-11-05	アボツト・ラボラトリーズ	化学的シナプス伝達の制御に有用なフロピリジン、チエノピリジン、ピロロピリジンおよび関連するピリミジン、ピリダジンおよびトリアジン化合物
GB9519558D0 (en) *	1995-09-26	1995-11-29	Merck Sharp & Dohme	Therapeutic agents
JPH09172344A (ja)	1995-12-19	1997-06-30	Murata Mfg Co Ltd	圧電共振子
US5733912A (en)	1997-02-19	1998-03-31	Abbott Laboratories	7A-heterocycle substituted hexahydro-1H-pyrrolizine compounds useful in controlling chemical synaptic transmission
AU736798B2 (en) *	1997-05-30	2001-08-02	Neurosearch A/S	9-Azabicyclo(3.3.1)non-2-ene and nonane derivatives as cholinergic ligands at nicotinic ACh receptors
ATE267199T1 (de) *	1997-05-30	2004-06-15	Neurosearch As	8-azabicyclo(3,2,1)oct-2-en- und octanderivate als liganden der nicotinergen ach rezeptoren
GB9722343D0 (en) *	1997-10-22	1997-12-17	British Telecomm	Distributed virtual environment
PT1027336E (pt) *	1997-10-27	2005-01-31	Neurosearch As	Heteroarildiazacicloalcanos como ligandos colinergicos de receptores nocotinicos de acetilcolina
US6632823B1 (en) *	1997-12-22	2003-10-14	Merck & Co., Inc.	Substituted pyridine compounds useful as modulators of acetylcholine receptors
DK1068208T3 (da) *	1998-04-02	2003-09-01	Targacept Inc	Azatricyclo[3.3.1.1]dekanderivater og farmaceutiske sammensætninger, der indeholder dem
PA8474101A1 (es) *	1998-06-19	2000-09-29	Pfizer Prod Inc	Compuestos de pirrolo [2,3-d] pirimidina
JP2000026408A (ja)	1998-07-02	2000-01-25	Dai Ichi Seiyaku Co Ltd	対掌体的に純粋なピロリジン誘導体、その塩、それらの製造方法
US6804251B1 (en)	1998-11-12	2004-10-12	Broadcom Corporation	System and method for multiplexing data from multiple sources
FR2786769B1 (fr) *	1998-12-04	2002-10-25	Synthelabo	Derives de 2,5-diazabicyclo[2.2.1]heptane, leur preparation et leur application en therapeutique
EP1359152B1 (en) *	1999-01-29	2008-05-07	Abbott Laboratories	Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands
EP1177196B1 (en) *	1999-05-04	2004-03-10	Neurosearch A/S	Heteroaryl diazabicycloalkanes, their preparation and use
CZ20014127A3 (cs) *	1999-05-21	2002-06-12	Abbott Laboratories	Heterocyklické substituované aminoazacykly uľitečné jako prostředky ovlivňující centrální nervový systém
CA2389553C (en) *	1999-12-14	2010-06-22	Neurosearch A/S	Heteroaryl-diazabicycloalkanes

2001
- 2001-04-26 MY MYPI20011984A patent/MY137020A/en unknown
- 2001-04-26 MY MYPI20055633A patent/MY145722A/en unknown
- 2001-04-27 SK SK10-2010A patent/SK287658B6/sk not_active IP Right Cessation
- 2001-04-27 EP EP10177450A patent/EP2298775A1/en not_active Withdrawn
- 2001-04-27 KR KR1020087031655A patent/KR100961406B1/ko not_active Expired - Fee Related
- 2001-04-27 CN CN2012103509141A patent/CN102863441A/zh active Pending
- 2001-04-27 CZ CZ20100538A patent/CZ302795B6/cs not_active IP Right Cessation
- 2001-04-27 CZ CZ20080677A patent/CZ302072B6/cs not_active IP Right Cessation
- 2001-04-27 KR KR1020097010331A patent/KR100947187B1/ko not_active Expired - Fee Related
- 2001-04-27 AR ARP010101990A patent/AR030421A1/es active IP Right Grant
- 2001-04-27 PE PE2001000385A patent/PE20011305A1/es not_active Application Discontinuation
- 2001-04-27 MX MXPA02010594A patent/MXPA02010594A/es active IP Right Grant
- 2001-04-27 CA CA002683045A patent/CA2683045A1/en not_active Abandoned
- 2001-04-27 CA CA002407094A patent/CA2407094C/en not_active Expired - Fee Related
- 2001-04-27 EP EP01944118A patent/EP1284976A2/en not_active Withdrawn
- 2001-04-27 PL PL398491A patent/PL398491A1/pl unknown
- 2001-04-27 CZ CZ20023765A patent/CZ301324B6/cs not_active IP Right Cessation
- 2001-04-27 HK HK03104885.7A patent/HK1054375A1/zh unknown
- 2001-04-27 IL IL15223101A patent/IL152231A0/xx not_active IP Right Cessation
- 2001-04-27 EP EP10177411A patent/EP2295437A1/en not_active Withdrawn
- 2001-04-27 KR KR1020097021390A patent/KR100947188B1/ko not_active Expired - Fee Related
- 2001-04-27 WO PCT/US2001/013798 patent/WO2001081347A2/en not_active Ceased
- 2001-04-27 CN CNB018117112A patent/CN100430398C/zh not_active Expired - Fee Related
- 2001-04-27 BR BR0107246-3A patent/BR0107246A/pt not_active IP Right Cessation
- 2001-04-27 HU HU0300602A patent/HUP0300602A3/hu unknown
- 2001-04-27 AU AU2001266559A patent/AU2001266559C1/en not_active Ceased
- 2001-04-27 PL PL01358340A patent/PL358340A1/xx unknown
- 2001-04-27 NZ NZ521734A patent/NZ521734A/en not_active IP Right Cessation
- 2001-04-27 CZ CZ20090553A patent/CZ302038B6/cs not_active IP Right Cessation
- 2001-04-27 AU AU6655901A patent/AU6655901A/xx active Pending
- 2001-04-27 JP JP2001578437A patent/JP4981232B2/ja not_active Expired - Fee Related
- 2001-04-27 CN CN2010102450796A patent/CN101935322A/zh active Pending
- 2001-04-27 KR KR1020027014385A patent/KR100899950B1/ko not_active Expired - Fee Related
- 2001-04-27 SK SK1681-2002A patent/SK287273B6/sk not_active IP Right Cessation
- 2001-05-22 TW TW090110172A patent/TWI311137B/zh not_active IP Right Cessation
- 2001-05-22 TW TW097145362A patent/TWI357903B/zh not_active IP Right Cessation
- 2001-05-22 TW TW095100404A patent/TWI323733B/zh not_active IP Right Cessation
- 2001-05-22 TW TW100130949A patent/TW201141871A/zh unknown
2002
- 2002-10-24 NO NO20025107A patent/NO324250B1/no not_active IP Right Cessation
- 2002-11-21 BG BG107303A patent/BG66151B1/bg unknown
2005
- 2005-03-07 MY MYPI20094589A patent/MY168244A/en unknown
2006
- 2006-08-06 IL IL177316A patent/IL177316A/en not_active IP Right Cessation
2009
- 2009-12-29 IL IL203035A patent/IL203035A/en not_active IP Right Cessation
2010
- 2010-03-17 BG BG110620A patent/BG110620A/bg unknown
2011
- 2011-09-15 JP JP2011202172A patent/JP2012041349A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
CA2407094A1 (en)	2001-11-01
WO2001081347A3 (en)	2002-01-31
BG107303A (bg)	2003-07-31
NO20025107D0 (no)	2002-10-24
KR20090013833A (ko)	2009-02-05
SK287658B6 (sk)	2011-05-06
IL177316A0 (en)	2006-12-10
CZ302795B6 (cs)	2011-11-16
CZ302072B6 (cs)	2010-09-29
IL152231A0 (en)	2003-05-29
KR20020093955A (ko)	2002-12-16
CA2683045A1 (en)	2001-11-01
JP2012041349A (ja)	2012-03-01
PL358340A1 (en)	2004-08-09
NO324250B1 (no)	2007-09-17
TW200617013A (en)	2006-06-01
KR100947188B1 (ko)	2010-03-12
TWI311137B (en)	2009-06-21
EP2298775A1 (en)	2011-03-23
MY145722A (en)	2012-03-30
KR100961406B1 (ko)	2010-06-09
TW200909432A (en)	2009-03-01
CN1440410A (zh)	2003-09-03
TWI357903B (en)	2012-02-11
BG110620A (bg)	2010-07-30
MY168244A (en)	2018-10-15
AU6655901A (en)	2001-11-07
AU2001266559C1 (en)	2005-11-17
BG66151B1 (bg)	2011-08-31
PE20011305A1 (es)	2001-12-31
CZ302038B6 (cs)	2010-09-15
JP2003531210A (ja)	2003-10-21
NZ521734A (en)	2004-10-29
CN100430398C (zh)	2008-11-05
KR20090121385A (ko)	2009-11-25
CZ20023765A3 (cs)	2003-02-12
HK1054375A1 (zh)	2003-11-28
BR0107246A (pt)	2002-10-01
CN102863441A (zh)	2013-01-09
MY137020A (en)	2008-12-31
KR100947187B1 (ko)	2010-03-12
CZ301324B6 (cs)	2010-01-13
AR030421A1 (es)	2003-08-20
AU2001266559B2 (en)	2005-03-03
EP2295437A1 (en)	2011-03-16
IL203035A (en)	2010-12-30
KR100899950B1 (ko)	2009-05-28
MXPA02010594A (es)	2003-05-14
JP4981232B2 (ja)	2012-07-18
TW201141871A (en)	2011-12-01
WO2001081347A2 (en)	2001-11-01
KR20090071654A (ko)	2009-07-01
EP1284976A2 (en)	2003-02-26
CN101935322A (zh)	2011-01-05
TWI323733B (en)	2010-04-21
PL398491A1 (pl)	2012-06-04
NO20025107L (no)	2002-12-19
SK16812002A3 (sk)	2003-04-01
CA2407094C (en)	2009-11-17
IL177316A (en)	2010-06-30
SK287273B6 (sk)	2010-05-07
HUP0300602A2 (hu)	2003-06-28

Publication	Publication Date	Title
HUP0300602A3 (en)	2005-12-28	Diazabicyclic central nervous system active agents, pharmaceutical compositions containing them and their use
HUP0200308A2 (en)	2002-06-29	Quinolinecarboxamides as antiviral agents, pharmaceutical compositions containing them and their use
HUP0302969A3 (en)	2005-05-30	Npyy5 antagonists, pharmaceutical compositions containing them and their use
HUP0204514A3 (en)	2004-07-28	Pyridinylimidazoles, pharmaceutical compositions containing them and their use
HUP0200859A3 (en)	2002-12-28	Cyclo-alkyl substituted benzimidazoles, pharmaceutical compositions containing them, their preparation and their use
HUP0301573A3 (en)	2004-03-29	Substituted arylpyrazines, pharmaceutical compositions containing them and their use
HUP0400784A3 (en)	2007-09-28	Bicyclic heterocondensated pyrrolcarboxamide derivatives, their use and pharmaceutical compositions containing them
AU7990501A (en)	2002-02-13	Azabicyclic compounds, preparation thereof and use as medicines, in particular as antibacterial agents
HUP0204081A3 (en)	2003-07-28	4-pyrimidinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use
HUP0200714A3 (en)	2003-01-28	Pharmaceutical compounds, pharmaceutical compositions containing them and their use
IL154981A0 (en)	2003-10-31	Substituted indoles, pharmaceutical compositions containing such indoles and their use as ppay-y-binding agents
HUP0204101A3 (en)	2004-05-28	3-aminoquinazolin-2,4-dione antibacterial agents, pharmaceutical compositions containing them and their use
HUP0400837A3 (en)	2007-11-28	2-phenyl-thiazole derivatives, their use and pharmaceutical compositions containing them
HUP0204474A3 (en)	2004-07-28	1h-imidazopyridine derivatives, pharmaceutical compositions containing them and their use
HUP0300798A3 (en)	2006-02-28	Substituted-triazolopyrimidines and their use as anticancer agents and pharmaceutical compositions containing them
HUP0301722A3 (en)	2004-03-29	Pyrimidine derivatives, pharmaceutical compositions containing them and their use
HUP0104795A3 (en)	2002-05-28	Azabicycloalkanes as ccr5 modulators, pharmaceutical compositions comprising thereof and their use
HUP0303069A3 (en)	2004-04-28	Imidazole derivatives, pharmaceutical compositions containing them and their use
HUP0204413A3 (en)	2003-07-28	Quinazoline compounds, their preparation, their use and pharmaceutical compositions containing them
HUP0202678A3 (en)	2004-06-28	Certain alkylene diamine-substituted pyrazolo[1,5,-a]-1,5-pyrimidines and pyrazolo[1,5-a]-1,3,5-triazines, pharmaceutical compositions containing them and their use
CZ20012028A3 (cs)	2001-09-12	Nové N-substituované 2-kyanopyrrolidiny, farmaceutický prostředek, který je obsahuje a jejich použití jako léčivo
HUP0103884A3 (en)	2002-11-28	Arylsulfonanilide urea-derivatives, pharmaceutical compositions containing them and their use
HUP0203194A3 (en)	2004-01-28	Phenylpiperazines, pharmaceutical compositions containing them and their use
HUP0203735A3 (en)	2005-03-29	4-pyridinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use
HUP0400967A3 (en)	2004-10-28	Substituted 2-anilino-benzimidazoles, their use and pharmaceutical compositions containing them

Legal Events

Date	Code	Title	Description
2013-12-30	GB9A	Succession in title	Owner name: ABBVIE INC., US Free format text: FORMER OWNER(S): ABBOTT LABORATORIES, US
2015-01-28	FD9A	Lapse of provisional protection due to non-payment of fees

Date

Code

Title

Description

2013-12-30

GB9A

Succession in title

Owner name: ABBVIE INC., US

Free format text: FORMER OWNER(S): ABBOTT LABORATORIES, US

2015-01-28

FD9A

Lapse of provisional protection due to non-payment of fees